scholarly journals Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load

2013 ◽  
Vol 31 (5-6) ◽  
pp. 426-433
Author(s):  
Soo Ryang Kim ◽  
Ahmed El-Shamy ◽  
Susumu Imoto ◽  
Ke Ih Kim ◽  
Kayo Sugimoto ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Viral Load ◽  
Hepatitis C ◽  
Combination Therapy ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
High Viral Load ◽  
Prediction Of Response

scholarly journals Pegylated interferon α-2b/ribavirin combination therapy for elderly patients with chronic hepatitis C with high viral load of HCV genotype 1b

Kanzo ◽  
2008 ◽  
Vol 49 (4) ◽  
pp. 145-152
Author(s):  
Soo Ryang Kim ◽  
Susumu Imoto ◽  
Shuichi Fuki ◽  
Ke Ih Kim ◽  
Miyuki Taniguchi ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Viral Load ◽  
Hepatitis C ◽  
Combination Therapy ◽  
Elderly Patients ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
High Viral Load ◽  
Interferon Α ◽  
Hcv Genotype

scholarly journals Response factors to pegylated interferon-alfa/ribavirin treatment in chronic hepatitis C patients genotype 1b

2014 ◽  
Vol 66 (1) ◽  
pp. 193-201 ◽  
Author(s):  
Snezana Jovanovic-Cupic ◽  
S. Glisic ◽  
M. Stanojevic ◽  
N. Vasiljevic ◽  
T. Bojic-Milinovic ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Viral Load ◽  
Hepatitis C ◽  
Combination Therapy ◽  
Chronic Hepatitis C ◽  
Sustained Viral Response ◽  
Therapy Response ◽  
Pegylated Interferon ◽  
Response To Therapy ◽  
Genotype 1B

Hepatitis C virus infection is the most common chronic blood-borne infection and one of the most important causes of chronic liver disease. Knowing the predictors associated with pegylated interferon/ribavirin (PEG-IFN/RBV) combination therapy response is important for evidence-based treatment recommendations. The goal of this study was to identify host and viral factors of response to PEG-IFN/RBV treatment in chronic hepatitis C genotype 1b patients. We have examined the relationship between gender, age, level of alanine aminotransferase (ALT), viral load and liver fibrosis progression on therapy response. ALT level and viral load were evaluated before starting treatment with combination therapy. The elevated levels of ALT and route of HCV transmission were found to be significantly associated with the response to therapy in HCV-infected patients. Our findings may be useful for estimating a patient?s likelihood of achieving sustained viral response.

837 PREDICTION OF RESPONSE TO PEG-IFN/RBV THERAPY FOR CHRONIC HEPATITIS C GENOTYPE 2a AND 2b WITH HIGH VIRAL LOAD

2013 ◽  
Vol 58 ◽  
pp. S343
Author(s):  
S.R. Kim ◽  
A. El-Shamy ◽  
I. Shoji ◽  
S. Imoto ◽  
K.I. Kim ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Viral Load ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
High Viral Load ◽  
Prediction Of Response
Sign in / Sign up

Export Citation Format

Share Document